Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

ANTIVIRALS

New options to treat influenza B

Nature Microbiology volume 2, pages 1342–1343 (2017)Cite this article

Subjects

Influenza B virus causes substantial illness globally, particularly in children. Treatment options are limited, as the most widely used antiviral drug appears to be less effective than against influenza A. A new antibody targeting the influenza B neuraminidase shows promise in mice as a therapeutic option.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Roles of viral neuraminidase and anti-neuraminidase monoclonal antibodies in influenza virus infection.

References

  1. Rolfes, M. et al. Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths Averted by Vaccination in the United States (CDC, 2016).

  2. Lafond, K. E. et al. PLoS Med. 13, e1001977 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Paul Glezen, W., Schmier, J. K., Kuehn, C. M., Ryan, K. J. & Oxford, J. Am. J. Public Health. 103, e43–e51 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Tran, D. et al. Pediatrics http://doi.org/f85zsf (2016).

  5. Wohlbold, T. J. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-017-0011-8 (2017).

    PubMed  Google Scholar 

  6. Sugaya, N. et al. Clin. Infect. Dis. 44, 197–202 (2017).

    Article  Google Scholar 

  7. Kallewaard, N. L. et al. Cell 166, 596–608 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Muthuri, S. G. et al. Lancet Respir. Med. 2, 395–404 (2014).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. WHO Collaborating Centre for Reference and Research on Influenza and Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Vic 3000, Australia

    Aeron C. Hurt & Kanta Subbarao

Authors
  1. Aeron C. Hurt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kanta Subbarao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kanta Subbarao.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hurt, A.C., Subbarao, K. New options to treat influenza B. Nat Microbiol 2, 1342–1343 (2017). https://doi.org/10.1038/s41564-017-0027-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41564-017-0027-0

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing